Ask The Pharmacist: FDA Approval of Non-Opioid Medication for Acute Pain
3 MIN READ
The U.S. Food and Drug Administration (FDA) recently approved Journavx (suzetrigine), a novel non-opioid medication developed by Vertex Pharmaceuticals for the treatment of moderate to severe acute pain in adults. This approval, announced on January 30, 2025, marks a significant milestone in pain management, introducing the first new class of oral medication for acute pain in over two decades.
10 Ways Field Case Management Can Make a Difference
4 MIN READ
Enlyte's field case management provides empathetic, innovative support for injured employees, guiding recovery with tailored solutions. Discover how our comprehensive approach can enhance your workers' compensation outcomes.
Specialty Solutions Spotlight: The Critical Role of Quality Clinical Documentation in Workers' Comp
2 MIN READ
In workers' compensation cases, timely and thorough clinical documentation is essential for effective case management and optimal injured employee outcomes. However, obtaining and reviewing these documents often presents significant challenges.
Ask The Pharmacist: Buprenorphine’s Role in Workers’ Compensation Pain Management
3 MIN READ
Buprenorphine, a Schedule III controlled substance approved by the U.S. Food and Drug Administration (FDA), is increasingly being considered for pain management in workers' compensation cases. This partial opioid agonist offers a unique profile that balances effective pain relief with a lower risk of abuse and dependence compared to full opioid agonists.
Long-Term Catastrophic Assessments
2 MIN READ
Enlyte offers Long-Term Catastrophic Assessments for workers' comp claims. Our comprehensive evaluations help manage complex cases, prevent complications, and ensure proper care.
Specialty Solutions Spotlight: Massage Ball Therapy Tips
3 MIN READ
Massage balls offer a simple, portable, and highly effective solution to ease stiffness, reduce tension, and support employees in regaining movement and confidence. Designed to target specific areas of discomfort, they soothe trigger points and boost circulation—promoting faster healing without the need for outside assistance.
Ask The Pharmacist: Asthma and Smoke Inhalation Treatments
5 MIN READ
Asthma is a common chronic respiratory disease that leads to difficulty breathing due to the presence of inflammation and bronchoconstriction. It’s often triggered by allergens, irritants or infections and in some occupational settings, employees may develop asthma or experience exacerbations because of airborne irritants, such as smoke or certain chemical agents (e.g., ash, pesticides, mineral dust, sawdust, etc.). The treatment of asthma focuses on controlling inflammation, preventing bronchospasm and minimizing exposure to environmental triggers.
Stay Ahead in P&C
Get monthly insights from Enlyte experts to tackle your toughest claims challenges.